NCT05269485View on ClinicalTrials.gov

Hypofraction Radiotherapy for Locally Advanced Non-small Cell Lung Cancer

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

December 1, 2024

Study Completion Date

December 1, 2024

Conditions
Toxicity Due to RadiotherapyNon-small Cell Lung Cancer
Interventions
RADIATION

High-dose fractionated radiotherapy

Patients in this arm would receive high-dose fractionated radiotherapy with 60-68Gy/15-17f with one-year immunotherapy maintenance.

RADIATION

Low-dose fractionated radiotherapy

Patients in this arm would receive high-dose fractionated radiotherapy with 48Gy/15-12f with one-year immunotherapy maintenance.

Trial Locations (1)

Unknown

RECRUITING

Anhui Provicial Hospital, Hefei

All Listed Sponsors
lead

Anhui Provincial Hospital

OTHER_GOV